Lara Kelly

Lara Kelly is an accomplished professional in the field of clinical development and operations, currently serving as Associate Director of Clinical Development at KALA BIO since May 2023. Prior experience includes roles such as Clinical Study Manager at BioCryst Pharmaceuticals, and Clinical Study Manager at Lexitas Pharma Services. Lara has also held positions at Sio Gene Therapies, including Associate Director of Clinical Operations, and at Liquidia Technologies, progressing from Senior Associate Scientist to Senior Associate Study Manager. Educationally, Lara holds a Bachelor of Science in Pharmaceutical Sciences from Campbell University. Expertise includes nanoparticle formulation, analytical characterization, and manufacturing for vaccine development.